Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 2 |
2019 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for
luke van powering
Your search for
Luke Van Popering
retrieved no results
Surgical Management and Adjuvant Therapy for High-Risk and Metastatic Melanoma.
Am Soc Clin Oncol Educ Book. 2016;35:e505-14. doi: 10.1200/EDBK_159087.
Am Soc Clin Oncol Educ Book. 2016.
PMID: 27249760
Free article.
Review.
Whether completion lymph node dissection after a positive sentinel node biopsy improves survival is the question of current trials. The MSLT-2 study is best powered to show a potential benefit, but it has not yet reported any data. ...
Whether completion lymph node dissection after a positive sentinel node biopsy improves survival is the question of current trials. The MSLT …
Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.
van der Vinne N, Vollebregt MA, Boutros NN, Fallahpour K, van Putten MJAM, Arns M.
van der Vinne N, et al.
J Affect Disord. 2019 Dec 1;259:67-72. doi: 10.1016/j.jad.2019.08.016. Epub 2019 Aug 13.
J Affect Disord. 2019.
PMID: 31437703
Clinical Trial.
LIMITATIONS: Neurophysiological recordings were limited in time (two times 2-minute EEGs) and statistical power (n = 57 abnormal EEGs). CONCLUSIONS: Response rates in patients with normalized EEG taking sertraline were significantly larger than in subjects treated with esc …
LIMITATIONS: Neurophysiological recordings were limited in time (two times 2-minute EEGs) and statistical power (n = 57 abnormal EEGs …
Item in Clipboard
Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.
Bolla M, Maingon P, Carrie C, Villa S, Kitsios P, Poortmans PM, Sundar S, van der Steen-Banasik EM, Armstrong J, Bosset JF, Herrera FG, Pieters B, Slot A, Bahl A, Ben-Yosef R, Boehmer D, Scrase C, Renard L, Shash E, Coens C, van den Bergh AC, Collette L.
Bolla M, et al.
J Clin Oncol. 2016 May 20;34(15):1748-56. doi: 10.1200/JCO.2015.64.8055. Epub 2016 Mar 14.
J Clin Oncol. 2016.
PMID: 26976418
Clinical Trial.
Biochemical DFS, the primary end point, was defined from entry until PSA relapse (Phoenix criteria) and clinical relapse by imaging or death of any cause. The trial had 80% power to detect hazard ratio (HR), 0.714 by intent-to-treat analysis stratified by dose of RT at the …
Biochemical DFS, the primary end point, was defined from entry until PSA relapse (Phoenix criteria) and clinical relapse by imaging or death …
Item in Clipboard
Cite
Cite